| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 133749-24-3 | | 1-(2,4-dimethoxyphenyl)-5-oxopyrrolidine-3-carboxylic acid | | | | |
| 133749-60-7 | | 1-[4-(ethoxycarbonyl)phenyl]-5-oxopyrrolidine-3-carboxylic acid | | | | |
| 13375-29-6 | (二环丙基甲基)胺 | (dicyclopropylmethyl)amine | | | | |
| 13375-57-0 | 8-氮杂螺[二环[3.2.1]辛烷-3,2'-[1,3]二氧戊环] | 8-azaspiro[bicyclo[3.2.1]octane-3,2'-[1,3]dioxolane] | | | | |
| 13375-99-0 | | cis-syn-Bis(uraci1) | C8H8N4O4 | 224.17 | | |
| 133752-35-9 | | endothelin converting enzyme substrate | | | | |
| 1337523-99-5 | 6-溴-1,2,3,4-四氢萘-1-胺 | 6-bromo-1,2,3,4-tetrahydronaphthalen-1-amine | | | | |
| 1337529-56-2 | 索菲布韦杂质57 | sofosbuvir impurity 57 | | | | |
| 1337531-36-8 | 7-甲基-5-(1-((3-(三氟甲基)苯基)乙酰基)-2,3-二氢-1h-吲哚-5-基)-7h-吡咯并(2,3-d)嘧啶-4-胺 | gsk2606414 | | | | |
| 1337531-89-1 | | gsk perk inhibitor | | | | |
| 1337532-29-2 | | gsk2656157 | | | | |
| 1337532-51-0 | 6-氨基-7-溴-9-甲基-7-脱氮嘌呤 | 5-bromo-7-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine | | | | |
| 1337532-92-9 | 5-溴噻吩并[2,3-d]嘧啶-4-胺 | 5-bromothieno[2,3-d]pyrimidin-4-amine | | | | |
| 1337533-31-9 | n-boc-5-溴-4-氟吲哚啉 | tert-butyl 5-bromo-4-fluoroindoline-1-carboxylate | | | | |
| 1337533-85-3 | 5-(吲哚-5-基)-7-甲基-7h-吡咯并[2,3-d]嘧啶-4-胺二盐酸盐 | 5-(indolin-5-yl)-7-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine | | | | |
| 133754-43-5 | | castor oil, dehydrated, polymer with benzoic acid, pentaerythritol, phthalic an | | | | |
| 133754-44-6 | | benzenesulfonic acid, di-c8-16-alkyl derivs. | | | | |
| 133754-45-7 | | '-methylenebis[isocyanatobenzene], oxirane and 2,2'-oxybis[ethanol], me et keto | | | | |
| 133754-46-8 | | poly(oxy-1,2-ethanediyl), alpha-hydro- omega-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1),monomethyl ether | | | | |
| 133754-47-9 | | isotridecanoic acid, potassium salt | | | | |
| 1337549-35-5 | 3-乙氧基哌啶-1-羧酸叔丁酯 | tert-butyl 3-ethoxypiperidine-1-carboxylate | | | | |
| 1337559-89-3 | (2S,3S,4S,5S)-2-(3,4-二甲氧基苯基)-4-氟-5-(羟甲基)吡咯烷-3-醇 | (2S,3S,4S,5S)-2-(3,4-dimethoxyphenyl)-4-fluoro-5-(hydroxymethyl)pyrrolidin-3-ol | | | | |
| 1337559-91-7 | (5S,6S,7S,7as)-7-氟-5-(3-羟基-4-甲氧基苯基)-1,3,5,6,7,7a-六氢吡咯并[1,2-c]3]恶唑-6-醇 | (5S,6S,7S,7as)-7-fluoro-5-(3-hydroxy-4-methoxyphenyl)-1,3,5,6,7,7a-hexahydropyrrolo[1,2-c][1,3]oxazol-6-ol | | | | |
| 1337560-33-4 | (2S,3S,4S,5S)-3-(苄氧基)-5-((苄氧基)甲基)-4-氟-2-((R)-1-羟基丁-3-烯基)吡咯烷-1-羧酸苄酯 | (2S,3S,4S,5S)-benzyl 3-(benzyloxy)-5-((benzyloxy)methyl)-4-fluoro-2-((R)-1-hydroxybut-3-enyl)pyrrolidine-1-carboxylate | | | | |
| 13376-26-6 | | 1-(1-cyclohexen-1-yl)-2-(trifluoromethyl)benzene | | | | |
| 13376-40-4 | | (2,5-dichloro-4-cyclohexylphenyl)-acetic aci | | | | |
| 13376-74-4 | 硅酸镁,镁橄榄石 | magnesium silicate | H2Mg3O12Si4 | 379.26 | 1557℃ | |
| 13376-78-8 | 甲基乙酯磷 | acetic acid, mercaptophenyl-, ethyl ester, s-ester with o,o-dimethyl phosphorod | C12H17O4PS2 | 320.37 | | |
| 1337606-76-4 | 2,6-二氟-4-(溴甲基)苯甲酸甲酯 | methyl 4-(bromomethyl)-2,6-difluorobenzoate | | | | |
| 1337606-88-8 | | ethyl 2,6-difluoro-4-methylbenzoate | | | | |
| 1337606-96-8 | 4-环丙基-1-甲基-1h-咪唑 | 4-cyclopropyl-1-methyl-1h-imidazole | | | | |
| 133762-16-0 | | 3,4-dihydro-4-oxo-2(1h)-cinnolineacetic aci ethyl ester | | | | |
| 133762-95-5 | | methanesulfonamide, n-(2-chloro-5-(3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluorom | | | | |
| 133762-96-6 | | 2,4(1h,3h)-pyrimidinedione, 3-(4-chloro-3-(1-methylethoxy)phenyl)-1-methyl- 6-( | | | | |
| 133762-97-7 | | benzoic acid, 2-chloro-5-(6,7-dihydro-2,4-dioxo-2h-thiazolo(3,2-a)-1,3,5-triazi | | | | |
| 133762-98-8 | | benzoic acid, 2-chloro-5-(3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1( | | | | |
| 133762-99-9 | | ethyl)-1(2h)- pyrimidinyl)phenyl)- | | | | |
| 133763-16-3 | | em 405 | | | | |
| 133763-19-6 | | 2-(phenylazoxy)-1-methyl-6-phenylimidazo(4,5-b)pyridine | | | | |
| 133768-71-5 | | l 686741 | | | | |
| 1337693-87-4 | | 6-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | | | | |
| 13377-98-5 | | propionitrile, 3-[n-(2-hydroxyethyl)-4-[(2-hydroxy-4-nitrophenyl)azo]-m-toluidi | | | | |
| 133773-17-8 | | n,n-triethyl- (tb-5-12)-bromotriphenyl(thiocyanato-n)stannate(1-ethanamin | | | | |
| 133773-29-2 | | (R)-1-(2,4-dichlorophenyl)ethanamine | | | | |
| 133775-25-4 | (2R,3R)-2-(2,4-二氟苯基)-1-(1h-1,2,4-三唑-1-基)丁烷-2,3-二醇 | (2R,3R)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butane-2,3-diol | | | | |
| 133775-36-7 | | o-10- hydroxy-, hydrochloride, hydrate (2:2:3) (3ar-(3a-alpha,12-alpha,12a-alph | | | | |
| 133775-39-0 | | (3ar-(3a-alpha,12-alpha,12a-alpha,12b-alpha))-o-10- hydroxy-3a-methyl | | | | |
| 133775-41-4 | | isoquino(2,1,8-lma)carbazol-5(1h)-one, 2,3,3a,4,11,12,12a,12b-octahydro-12-(dim | | | | |
| 133783-29-6 | | 2(3h)-benzothiazolimine, 3-(2-(4-(2-pyridinyl)-1-piperazinyl)ethyl)-6-(trifluor | | | | |
| 133783-31-0 | | 2(3h)-benzothiazolimine, 3-(2-(4-(phenylmethyl)-1-piperazinyl)ethyl)-6-(trifluo | | | | |
m.cnreagent.com